Literature DB >> 26036478

Clinical outcomes and genetic expression profile in human liver graft dysfunction during ischemia/reperfusion injury.

J Paulino1, E Vigia2, P Marcelino3, O Abade4, J Sobral5, D Ligeiro4, A Carvalho6, M Alves7, A L Papoila7, H Trindade4, E Barroso2.   

Abstract

INTRODUCTION: This study aims to compare the molecular gene expression during ischemia reperfusion injury. Several surgical times were considered: in the beginning of the harvesting (T0), at the end of the cold ischemia period (T1), and after reperfusion (T2) and compared with graft dysfunction after liver transplant (OLT).
METHODS: We studied 54 patients undergoing OLT. Clinical, laboratory data, and histologic data (Suzuki classification) as well as the Survival Outcomes Following Liver Transplantation (SOFT) score were used and compared with the molecular gene expression of the following genes: Interleukin (IL)-1b, IL-6, tumor necrosis factor-α, perforin, E-selectin (SELE), Fas-ligand, granzyme B, heme oxygenase-1, and nitric oxide synthetase.
RESULTS: Fifteen patients presented with graft dysfunction according to SOFT criteria. No relevant data were obtained by comparing the variables graft dysfunction and histologic variables. We observed a statistically significant relation between SELE at T0 (P = .013) and IL-1β at T0 (P = .028) and early graft dysfunction.
CONCLUSIONS: We conclude that several genetically determined proinflammatory expressions may play a critical role in the development of graft dysfunction after OLT.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26036478     DOI: 10.1016/j.transproceed.2015.03.025

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  Resolving the graft ischemia-reperfusion injury during liver transplantation at the single cell resolution.

Authors:  Linhe Wang; Jie Li; Shuai He; Yang Liu; Haitian Chen; Shujiao He; Meixian Yin; Dawei Zou; Shirui Chen; Tao Luo; Xinyu Yu; Xuesi Wan; Shunwei Huang; Zhiyong Guo; Xiaoshun He
Journal:  Cell Death Dis       Date:  2021-06-08       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.